| 000 | 01554 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515092538.0 | ||
| 264 | 0 | _c20080304 | |
| 008 | 200803s 0 0 eng d | ||
| 022 | _a1350-9047 | ||
| 024 | 7 |
_a10.1038/sj.cdd.4402254 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBernal, J A | |
| 245 | 0 | 0 |
_aProliferative potential after DNA damage and non-homologous end joining are affected by loss of securin. _h[electronic resource] |
| 260 |
_bCell death and differentiation _cJan 2008 |
||
| 300 |
_a202-12 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aBase Sequence |
| 650 | 0 | 4 |
_aCamptothecin _xpharmacology |
| 650 | 0 | 4 | _aCell Cycle |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aCell Proliferation |
| 650 | 0 | 4 | _aCell Survival |
| 650 | 0 | 4 | _aChromosome Aberrations |
| 650 | 0 | 4 |
_aDNA _xmetabolism |
| 650 | 0 | 4 | _aDNA Breaks, Double-Stranded |
| 650 | 0 | 4 | _aDNA Damage |
| 650 | 0 | 4 | _aDNA Repair |
| 650 | 0 | 4 |
_aDoxorubicin _xpharmacology |
| 650 | 0 | 4 | _aGenomic Instability |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 |
_aNeoplasm Proteins _xgenetics |
| 650 | 0 | 4 |
_aRNA, Small Interfering _xmetabolism |
| 650 | 0 | 4 | _aSecurin |
| 700 | 1 | _aRoche, M | |
| 700 | 1 | _aMéndez-Vidal, C | |
| 700 | 1 | _aEspina, A | |
| 700 | 1 | _aTortolero, M | |
| 700 | 1 | _aPintor-Toro, J A | |
| 773 | 0 |
_tCell death and differentiation _gvol. 15 _gno. 1 _gp. 202-12 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.cdd.4402254 _zAvailable from publisher's website |
| 999 |
_c17482009 _d17482009 |
||